From Breakthrough to Impact: Launching the NeuroLife® Company

In today’s pharma and biotech industries, choosing the right R&D partner is a strategic decision that can shape the trajectory of your entire program. Beyond credentials and case studies, the real differentiator lies in how a partner thinks, collaborates, and evolves. Here's four key questions every leader should ask before hiring a R&D partner.

Monitoring carbon dioxide plume movement is critical to protecting drinking water and meeting long-term regulatory requirements at CCS sequestration sites. This blog explores seismic and alternative monitoring methods and how integrated approaches can deliver accurate, compliant, long-term oversight of CO₂ storage.

MedTech companies are buying their way to innovation. Pharma and biotech are building networks to share the load. Both are responding to the same forces—rising R&D costs, regulatory complexity and pressure to move faster with less—but the strategies couldn't look more different.

Nuclear energy is entering a new era as advanced fuels, next‑generation reactors and modern recycling approaches reshape what’s possible. In this conversation, Andy Griffith shares insights from a career spanning the Navy and DOE, highlighting how innovation, safety and real-world demand are driving the future of clean, reliable nuclear power.

A MedTech startup came to us with a promising wound-management concept, early IP and a working prototype. From their perspective, they had already solved the hardest problem. But as we dug in, a different reality emerged.